Biocon Plots Biosimilars Listing By 2023

Indian Firm Eyeing $1bn In Sales From Biosimilars In Two Years

 
• By Dean Rudge
  
IPO
An IPO for Biocon Biologics is planned by 2023 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business